 |
AdAlta Limited (ASX: 1AD) is a clinical-stage biotechnology company using its unique i-body platform to develop novel protein therapeutics addressing drug targets that have proven challenging to traditional antibody technologies. The lead asset, AD-214, is being developed for fibrotic disease, initially for the degenerative orphan disease Idiopathic Pulmonary Fibrosis (IPF) and is now in Phase I clinical trials, providing clinical validation of the platform. A collaboration with GE Healthcare to develop a diagnostic imaging agent provides commercial validation of the platform. AdAlta plans to add more internal and external pipeline assets over time.
Speaker: Dr Tim Oldham, Managing Director and Chief Executive Officer
Presentation slides
|
 |
Anatara Lifesciences Limited (ASX: ANR) is developing an OTC medicine to address factors associated with gastrointestinal (GI) disorders such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD): microbiome dysbiosis, inflammation and mucosal damage. With preclinical development successfully completed, a clinical trial is anticipated in late 2020. IBS affects 11% of people globally. Patients experience high failure rates of prescription therapies and have a poor quality of life. 50% of IBS patients seek symptomatic relief through the use of adjunct therapies and complementary medicines. Anatara’s product is positioned as an adjunct to existing therapies to empower patients to better manage their symptoms.
Speaker: Steve Lydeamore, Chief Executive Officer
Presentation slides
|
 |
Atomos Limited (ASX: AMS) is a global software and hardware technology company that creates, develops and commercialises ground-breaking products for the rapidly growing content creation market. The business was founded in 2010 when it created the world’s first video monitor-recorder. That monitor-recorder converged separate existing and more expensive products and allowed users to transform the quality of the editing and production output of their video camera for a fraction of the cost than had previously been the case. Since that day Atomos, working alongside an ever-expanding ecosystem of key technology providers that include Apple, Adobe, Sony, Canon, JVC Kenwood, Nikon, FUJIFILM and Panasonic, has been part of the rapid ‘democratisation’ and expansion of high-quality and accessible video content creation.
Speaker: Chris Tait, Non-Executive Director and Chairman
Presentation slides
|
 |
Canterbury Resources Limited (ASX: CBY) is an active explorer with a portfolio of projects in the southwest Pacific that are prospective for large-scale porphyry style copper-gold deposits, providing high leverage for investors. Exploration cost and risk are defrayed by partnering with majors wherever possible. Since listing, Canterbury has undertaken drill programs at the Ekoato and Bismarck copper-gold projects in PNG and the Briggs copper project in Queensland. A Mineral Resource estimate has been completed at Briggs (142.8 Mt at 0.29% Cu) and an estimate is being undertaken at the strategically significant Wamum application in PNG where historical exploration has outlined two large gold-copper deposits.
Speaker: Grant Craighead, Managing Director
Presentation slides
|
 |
Founders First Limited (ASX: FFL) is an Australian based craft beverage ‘accelerator’ operated by a group of leading liquor industry professionals. The company invests in select craft beverage businesses alongside their founders and accelerates their growth through the provision of capital, sales and marketing, supply chain and management expertise and the operation of venues.
Speaker: Mark Haysman, Chief Executive Officer
Presentation slides
|
 |
IntelliHR Limited (ASX: IHR) The workplace has suddenly shifted forever and the key challenge business now faces is the transition to a distributed office and how to improve team engagement and effectiveness around the world. IntelliHR’s next-generation cloud-based people management and data analytics platform is perfectly positioned to play a leading role in driving this change. This is why leading tech entrepreneur Bevan Slattery has recently invested heavily with the business having already attracted many blue-chip customers and achieved growth of over 250% during the last 2 years. The significant investment in product and customer growth over the past 5 years has positioned intelliHR well for this global transformation.
Speaker: Robert Bromage, Founder and Managing Director
Presentation slides
|
 |
Lark Distilling Co. Limited (ASX: LRK) is Tasmania’s leading luxury whisky brand. Our vision is to make Lark whisky a globally consumed, recognised and much-loved Tasmanian brand icon that celebrates our connection to the craft, the community and each other. Proudly “MADE of TASMANIA” and producing Tasmania’s first whisky, Lark, founded by Bill Lark, and now under the leadership of Geoff Bainbridge (MD) & David Dearie (Chair) is at the cusp of an exciting era of growth and innovation with the resulting creation of meaningful shareholder value. Comprising over 711,000 litres of maturing whisky with a net sales value at the maturation of approximately $98m, the agreed strategy is to Make Lark the “Penfolds” of Australian Whisky.
Speaker: Geoff Bainbridge, Managing Director
Presentation slides
|
 |
New Zealand King Salmon Investments Limited (ASX: NZK) is the world’s largest producer of King salmon. With more than 30 years’ experience in farming, processing and branding our unique breed, we are passionate about creating the ultimate salmon experience. Based in the top of the South Island of New Zealand, our King salmon are sustainably raised in some of the cleanest rearing environments in the world. From the crystal-clear waters of Te Waikoropupū Springs near Takaka, to the majestic marine environment that is the Marlborough Sounds; our King salmon is the highest quality you can get.
Speaker: Grant Rosewarne, Chief Executive Officer and Managing Director
Presentation slides
|
 |
OpenLearning Limited (ASX: OLL) is a software as a service company that provides a scalable online learning platform to education providers and a global marketplace of world-class courses for learners of all levels. OpenLearning’s platform enables the delivery of project-based, social learning to encourage interaction among users and foster a community of collaborative learners. The company’s unique service provides a complete learning environment for all types of online education - from short courses through to micro-credentials and online degrees. With more than 2.17 million learners worldwide across over 8,000 courses provided by 76 education providers.
Speaker: Adam Brimo, Chief Executive Officer
Presentation slides
|
 |
Regeneus Limited (ASX: RGS) is an Australian regenerative medicine company aiming to improve the quality of life of patients suffering from pain. The company uses its stem cell technologies to develop a portfolio of novel cell-based therapies, focusing on neuropathic pain, including osteoarthritis, and various skin conditions. It has two lead platform technologies, Progenza and Sygenus. Visit Regeneus.com.au for more information.
Speaker: Leo Lee, Chief Executive Officer
Presentation slides
|
 |
SunRice (Ricegrowers Limited) (ASX: SGLLV) is a global FMCG business and one of Australia’s leading branded food exporters. With revenues in excess of $1 billion and operations and markets spanning the globe, we supply close to 50 countries with diverse and nutritious food products, and our operations and assets span Australia, the Middle East, the US, Papua New Guinea, the Pacific and Asia. In addition to our specialisation in branded rice and rice-based foods, SunRice also has business segments that a focus on gourmet Mediterranean foods and food service supply; stockfeed production and companion animal feed nutrition expertise; and food ingredients supply to manufacturers of household brands across multiple sectors.
Speaker: Dimitri Courtelis, Chief Financial Officer
Presentation slides
|
 |
Visioneering Technologies Inc. (ASX: VTI) is a US medical device company. Our flagship product is a contact lens used in two populations with high needs: children who are nearsighted, which is 80-90% of children in industrialized Asia and a quarter to a third of children in the US, and over-45 adults who have difficulty seeing objects that are within arm's length. Since listing on ASX in 2017, we have grown from selling US$200K of product in the US 2016 to selling almost $6M in 2019, with regulatory clearances in EU, ANZ, Singapore, Hong Kong, and Canada. We have entered our first relationship with a multi-national contact lens company, validating our product and market. The company is well-positioned for additional growth.
Speaker: Stephen Snowdy, PhD, Chief Executive Officer and Executive Director
Presentation slides
|
 |
Wellness and Beauty Solutions Limited (ASX: WNB) has a suite of owned, licensed and joint venture partnerships which supplies wellness, beauty and lifestyle products in Australasia. Our suite of brands is sold to the professional and retail markets via an e-commerce platform, agency partnerships and through our wholly-owned subsidiaries The Giving Brands Company (GBCo) and True Solutions International (TSI) and our joint venture with MICRO 19. Wellness and Beauty Solutions owns and a network of nine Immersion Clinical Spas in Australia that provide non-invasive medical aesthetic (NIMA) and wellness and beauty services.
Speaker: Christine Parkes, Chief Executive Officer and Managing Director
Presentation slides
|
 |
Wide Open Agriculture Limited (ASX: WOA) is Australia’s leading regenerative food and agriculture company. Its food brand, Dirty Clean Food, has ambitions to become Australia’s leading online sales platform for ethical and regenerative food products. The company recently achieved its fourth consecutive quarter of revenue growth. Working with Curtin University and CSIRO, WOA is developing a novel plant-based protein from Australia Sweet Lupin and also exploring the certification, marketing and global distribution of carbon-neutral grain with CBH Group (CBH). WOA is also committed to being carbon neutral by 2023, both as a company and all its product lines.
Speaker: Dr Ben Cole, Managing Director
Presentation slides
|
